The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis

Ann Rheum Dis. 2011 Jul;70(7):1347-8. doi: 10.1136/ard.2010.146878. Epub 2011 Feb 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / therapeutic use*
  • Arthritis / drug therapy*
  • Familial Mediterranean Fever / drug therapy*
  • Female
  • Humans
  • Interleukin-1beta / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Interleukin-1beta
  • canakinumab